tiprankstipranks
Lixte Biotechnology announces presentation of LB-100
PremiumThe FlyLixte Biotechnology announces presentation of LB-100
2M ago
LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI
PremiumPress Releases
LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI
2M ago
Lixte Biotechnology enters patent license agreement with NINDS, NCI
PremiumThe Fly
Lixte Biotechnology enters patent license agreement with NINDS, NCI
2M ago
LIXTE Biotechnology Provides Update on Clinical Progress and Expanding Collaborations
PremiumPress ReleasesLIXTE Biotechnology Provides Update on Clinical Progress and Expanding Collaborations
6M ago
Lixte Biotechnology, NKI, Oncode Institute expand collaboration
PremiumThe Fly
Lixte Biotechnology, NKI, Oncode Institute expand collaboration
7M ago
LIXTE Biotechnology Holdings Announces the Passing of its Founder, John S. Kovach
PremiumPress Releases
LIXTE Biotechnology Holdings Announces the Passing of its Founder, John S. Kovach
7M ago
Lixte Biotechnology files to sell 583,334 shares of common stock for holders
PremiumThe FlyLixte Biotechnology files to sell 583,334 shares of common stock for holders
9M ago
LIXTE Biotechnology Announces Closing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules
PremiumPress Releases
LIXTE Biotechnology Announces Closing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules
10M ago
Lixte Biotechnology to sell 583,334 shares at $6.00 in registered direct offerin
PremiumThe Fly
Lixte Biotechnology to sell 583,334 shares at $6.00 in registered direct offerin
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100